List of bibliographic references indexed by Parkinson Disease, Secondary (chemically induced)
Number of relevant bibliographic references: 113.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000055 (2017) |
Renato P. Munhoz [Canada] ; Delcio Bertucci Filho [Brésil] ; Hélio A G. Teive [Brésil] | Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype. |
| 000060 (2017) |
Karim Selfani [Canada] ; Valérie L. Soland ; Sylvain Chouinard ; Philippe Huot | Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole. |
| 000424 (2016) |
Marc Morissette [Canada] ; Nicolas Morin [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada] | Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients. |
| 000523 (2015) |
Emily M. Rocha [États-Unis] ; Gaynor A. Smith [États-Unis] ; Eric Park [États-Unis] ; Hongmei Cao [États-Unis] ; Anne-Renee Graham [États-Unis] ; Eilish Brown [États-Unis] ; Jesse R. Mclean [États-Unis] ; Melissa A. Hayes [États-Unis] ; Jonathan Beagan [États-Unis] ; Sarah C. Izen [États-Unis] ; Eduardo Perez-Torres [États-Unis] ; Penelope J. Hallett [États-Unis] ; Ole Isacson [États-Unis] | Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice. |
| 000630 (2015) |
Umar A. Shuaib ; Ali H. Rajput ; Christopher A. Robinson ; Alex Rajput | Neuroleptic‐induced Parkinsonism: Clinicopathological study |
| 000648 (2015) |
Yueting Shao [Canada] ; Daniel Figeys ; Zhibin Ning ; Ryan Mailloux ; Hing Man Chan | Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. |
| 000742 (2015) |
Eric J. Lenze [États-Unis] ; Benoit H. Mulsant [Canada] ; Daniel M. Blumberger [Canada] ; Jordan F. Karp [États-Unis] ; John W. Newcomer [États-Unis] ; Stewart J. Anderson [États-Unis] ; Mary Amanda Dew [États-Unis] ; Meryl A. Butters [États-Unis] ; Jacqueline A. Stack [États-Unis] ; Amy E. Begley [États-Unis] ; Charles F. Reynolds [États-Unis] | Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. |
| 000985 (2014) |
Jackalina M. Van Kampen [Canada] ; David B. Baranowski [Canada] ; Christopher A. Shaw [Canada] ; Denis G. Kay | Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease. |
| 000999 (2014) |
Nicolas Morin [Canada] ; Vincent A. Jourdain [Canada] ; Thérèse Di Paolo [Canada] | Modeling dyskinesia in animal models of Parkinson disease. |
| 000D90 (2013) |
Jovana Lubarda [Canada] ; Sarah E. Groleau ; Nancy Thomas ; Mark A. Ferro ; Ram K. Mishra ; Joseph P. Gabriele | Dysregulation of novel catecholamine-regulated protein 40 (CRP40) in Parkinson's disease patients. |
| 000E82 (2013) |
Sharon Miksys ; Rachel F. Tyndale | 2011 CCNP Heinz Lehmann Award paper: Cytochrome P450–mediated drug metabolism in the brain |
| 001182 (2012) |
C J Yong-Kee [Canada] ; E. Sidorova ; A. Hanif ; G. Perera ; J E Nash | Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson's disease. |
| 001206 (2012) |
Russell C. Callaghan [Canada] ; James K. Cunningham ; Jenna Sykes ; Stephen J. Kish | Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. |
| 001267 (2012) |
Pierre J. Blanchet [Canada] ; Louise Normandeau ; Pierre H. Rompré | Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot study. |
| 001280 (2012) |
Connie Marras [Canada] ; Nathan Herrmann ; Geoffrey M. Anderson ; Hadas D. Fischer ; Xuesong Wang ; Paula A. Rochon | Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex. |
| 001567 (2011) |
Melanie Bousquet [Canada] ; Karl Gue [Canada] ; Vincent Emond [Canada] ; Pierre Julien [États-Unis] ; Jing X. Kang [États-Unis] ; Francesca Cicchetti [Canada] ; Frederic Calon [Canada] | Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease |
| 001646 (2011) |
Arman Lira ; Jerzy Kulczycki ; Ruth Slack ; Hymie Anisman ; David S. Park | Involvement of the Fcγ Receptor in a Chronic N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Dopaminergic Loss* |
| 001703 (2011) |
Boris Rosin [Israël] ; Maya Slovik ; Rea Mitelman ; Michal Rivlin-Etzion ; Suzanne N. Haber ; Zvi Israel ; Eilon Vaadia ; Hagai Bergman | Closed-loop deep brain stimulation is superior in ameliorating parkinsonism. |
| 001986 (2010) |
Susan H. Fox [Canada] ; Jonathan M. Brotchie | The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. |
| 001996 (2010) |
Tom H. Johnston [Canada] ; Susan H. Fox ; Matthew J. Mcildowie ; Matthew J. Piggott ; Jonathan M. Brotchie | Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. |
| 001A51 (2010) |
Qingjia Meng [Canada] ; Dirk W. Luchtman ; Bouchaib El Bahh ; Jeffrey A. Zidichouski ; Jun Yang ; Cai Song | Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease, Secondary (chemically induced)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \
-Sk "Parkinson Disease, Secondary (chemically induced)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdEn.i
|clé= Parkinson Disease, Secondary (chemically induced)
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
